3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Lymphatic Metastasis
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Breast Cancer Lymphedema
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Right Hemicolectomy
1
Rhabdomyosarcoma
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Mixed Tumor, Mesodermal
1
Mesothelioma, Malignant
1
Melanoma
1
Margins of Excision
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Giant Cell Tumor of Tendon Sheath
1
Interventions
Cyclophosphamide
51
fludarabine
37
Dexamethasone
35
venetoclax
30
pembrolizumab
25
Rituximab
21
pomalidomide
18
Lenalidomide
18
Gemcitabine
17
fludarabine phosphate
15
Etoposide
14
Cytarabine
13
daratumumab
12
carfilzomib
11
Temozolomide
11
Injections
10
Cisplatin
10
Calcium Dobesilate
10
glofitamab
9
Nivolumab
9
Bortezomib
9
Azacitidine
9
selinexor
8
Vincristine
8
Immunotherapy, Adoptive
8
Carboplatin
8
obinutuzumab
7
cemiplimab
7
Drug Therapy
7
Bevacizumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Indocyanine Green
×
1 year
×
Clear all
No trials found.